Carbonyl Stress and Diabetic Complications (Q35576070)

8 August 2017

1 reference

title

Carbonyl stress and diabetic complications (English)

1 reference

8 August 2017

Carbonyl Stress and Diabetic Complications (English)

1 reference

DOI

https://api.crossref.org/works/10.1515/CCLM.2003.178

Charles van Ypersele de Strihou

28 March 2024

author

series ordinal

object named as

Charles van Ypersele de Strihou

1 reference

8 August 2017

Toshio Miyata

1 reference

8 August 2017

Naoyoshi Ishikawa

series ordinal

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14598864

28 March 2024

publication date

1 September 2003

1 reference

full work available at URL

8 August 2017

https://www.degruyter.com/document/doi/10.1515/CCLM.2003.178/pdf

1 reference

DOI

https://api.crossref.org/works/10.1515/CCLM.2003.178

Clinical Chemistry and Laboratory Medicine

28 March 2024

published in

1 reference

8 August 2017

1 reference

8 August 2017

1 reference

8 August 2017

page(s)

1150-1158

1 reference

Accelerated age-related browning of human collagen in diabetes mellitus

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Two novel rat liver membrane proteins that bind advanced glycosylation endproducts: relationship to macrophage receptor for glucose-modified proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Phosphorylation of SLP-76 by the ZAP-70 protein-tyrosine kinase is required for T-cell receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Identification of pentosidine as a native structure for advanced glycation end products in beta-2-microglobulin-containing amyloid fibrils in patients with dialysis-related amyloidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Accumulation of Maillard reaction products in skin collagen in diabetes and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Maillard reaction products and their relation to complications in insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Transition metals redox: reviving an old plot for diabetic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Oxidation conspires with glycation to generate noxious advanced glycation end products in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Implication of an increased oxidative stress in the formation of advanced glycation end products in patients with end-stage renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

A hydroxyl radical-like species oxidizes cynomolgus monkey artery wall proteins in early diabetic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Polyol pathway activation and glutathione redox status in non-insulin-dependent diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Metabolic alterations in the human erythrocyte produced by increases in glucose concentration. The role of the polyol pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Efficient in vitro lowering of carbonyl stress by the glyoxalase system in conventional glucose peritoneal dialysis fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Mechanism of autoxidative glycosylation: identification of glyoxal and arabinose as intermediates in the autoxidative modification of proteins by glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Reaction of ascorbate with lysine and protein under autoxidizing conditions: formation of N epsilon-(carboxymethyl)lysine by reaction between lysine and products of autoxidation of ascorbate

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Protein-bound acrolein: potential markers for oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha,beta-unsatu

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Plasma malondialdehyde in type 1 and type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Glyoxal and methylglyoxal trigger distinct signals for map family kinases and caspase activation in human endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Toward better dialysis compatibility: advances in the biochemistry and pathophysiology of the peritoneal membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Affinity adsorption of glucose degradation products improves the biocompatibility of conventional peritoneal dialysis fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Pyridoxamine inhibits early renal disease and dyslipidemia in the streptozotocin-diabetic rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Angiotensin II receptor antagonists and angiotensin-converting enzyme inhibitors lower in vitro the formation of advanced glycation end products: biochemical mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Anti-Hypertensive Agents Inhibit In Vivo the Formation of Advanced Glycation End Products and Improve Renal Damage in a Type 2 Diabetic Nephropathy Rat Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2003.178

Relation between complications of type I diabetes mellitus and collagen-linked fluorescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Detection of D-glucose-derived pyrrole compounds during Maillard reaction under physiological conditions

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Crosslines A and B as candidates for the fluorophores in age- and diabetes- related cross-linked proteins, and the diacetates produced by Maillard reaction of a-N-acetyl-L-lysine with D-glucose.

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

New biomarkers of Maillard reaction damage to proteins

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Amyloid beta 2-microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

A sensitive and specific ELISA for plasma pentosidine

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

N.epsilon.-(Carboxymethyl)lysine Is a Dominant Advanced Glycation End Product (AGE) Antigen in Tissue Proteins

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Reactive glycosylation endproducts in diabetic uraemia and treatment of renal failure

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Autoxidation products of both carbohydrates and lipids are increased in uremic plasma: is there oxidative stress in uremia?

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

2-Isopropylidenehydrazono-4-oxo-thiazolidin-5-ylacetanilide (OPB-9195) treatment inhibits the development of intimal thickening after balloon injury of rat carotid artery: role of glycoxidation and lipoxidation reactions in vascular tissue damage

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Increased oxidative stress in mouse kidneys with unilateral ureteral obstruction

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Relevance of oxidative and carbonyl stress to long-term uremic complications.

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Advanced oxidation protein products as a novel marker of oxidative stress in uremia

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Implication of altered redox regulation by antioxidant enzymes in the increased plasma pentosidine, an advanced glycation end product, in uremia

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Alterations in nonenzymatic biochemistry in uremia: origin and significance of "carbonyl stress" in long-term uremic complications

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

The assay of methylglyoxal in biological systems byderivatization with 1,2-diamino-4,5-dimethoxybenzene

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Carbonyl compounds cross-link cellular proteins and activate protein-tyrosine kinase p60c-Src

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Advanced glycation and lipidoxidation of the peritoneal membrane: respective roles of serum and peritoneal fluid reactive carbonyl compounds

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

In vivo formation of a Schiff base of aminoguanidine with pyridoxal phosphate

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: comparison with aminoguanidine

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

Pyridoxamine, an inhibitor of advanced glycation reactions, also inhibits advanced lipoxidation reactions. Mechanism of action of pyridoxamine

28 March 2024

1 reference

https://api.crossref.org/works/10.1515/CCLM.2003.178

28 March 2024

Identifiers

DOI

1 reference

8 August 2017

1 reference